Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.2026
https://www.valueinhealthjournal.com/article/S1098-3015(13)03938-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1851
First Page :
A684
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03938-7&doi=10.1016/j.jval.2013.08.2026